AMELIA MONCHO: Open Payments
NPI 1205803863 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 39 payments from 13 companies in 2025. Trend: 2023 $1,425 · 2024 $1,788 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $238 |
| PFIZER INC. | 8 | $165 |
| Corcept Therapeutics | 8 | $151 |
| Lilly USA, LLC | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: Korlym, VRAYLAR, NURTEC ODT, QULIPTA, MOUNJARO, AREXVY, UBRELVY, XYOSTED.
Industry payments across OK — which companies pay providers there.
